Integration of Real-Time Motion Tracking and Pediatric Rehabilitation (Snipperfinger)

December 11, 2025 updated by: Thomas Caruso, Stanford University

Evaluating the Feasibility, Usability, and Integration of the OptiTrack Motion Capture System in Inpatient Physical Therapy

Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can contribute to deconditioning and functional mobility deficits. This study seeks to explore the feasibility of a tool designed to promote movement through engaging gameplay that is acceptable to both clinicians and families.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Recruiting
        • Lucile Packard Children's Hospital Stanford
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pediatric patients aged 6-17 years.
  • Receiving physical therapy at Stanford Children's Hospital.
  • Medically cleared for standing and upper-body movement.
  • Ability to follow simple instructions and engage in standing gameplay

Exclusion Criteria:

  • Orthopedic or medical conditions contraindicating physical activity.
  • Legal guardian not present to obtain consent
  • Child with a significant neurological condition or major developmental disability
  • Child with active infection of the face or hand
  • A history of severe motion sickness A history of seizures caused by flashing light Major surgery within the last 48 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pediatric patient
Pediatric patient will engage with engagement-focused software platform (Snipperfingers) and movement will be analysed by the real-time motion capture system (the OptiTrack system).
Snipperfinger is a self developed engagement focused software platform designed to encourage participation in pediatric physical therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the ease of use of Optitrack system measured by System Usability Scale (SUS)
Time Frame: Post-simulation (5 minutes)]
10-item questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale to measure usability.
Post-simulation (5 minutes)]

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Setup time required for system use
Time Frame: Before intervention
Time required to set up the system, defined as the duration from participant arrival in the gym to the start of the physical activity.
Before intervention
Duration of gameplay-driven physical activity
Time Frame: immediately at the start of intervention, immediately after intervention
Time from first recorded movement in response to gameplay to last movement as recorded by OptiTrack motion capture or clinician observation
immediately at the start of intervention, immediately after intervention
Evaluation parent's perception of patient's engagement.
Time Frame: immediately after intervention
Parent acceptance of the system will be evaluated by self developed questionnaire. The questionnaire contains 10 items with scale from 1-5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale.
immediately after intervention
Acceptability of Intervention Measure (AIM) survey
Time Frame: immediately after the intervention
This questionnaire consists of 4 items. Measures are to be graded using a 1-5 scale, from 1=completely disagree, to 5= completely agree
immediately after the intervention
Intervention Appropriateness Measure (IAM) survey
Time Frame: immediately after the intervention
This questionnaire consists of 4 items. Measures are to be graded using a 1-5 scale, from 1=completely disagree, to 5= completely agree
immediately after the intervention
Feasibility of Intervention Measure (FIM) survey
Time Frame: immediately after the intervention
This questionnaire consists of 4 items. Measures are to be graded using a 1-5 scale, from 1=completely disagree, to 5= completely agree
immediately after the intervention
ISO 9241-400
Time Frame: immediately after intervention
6-item ergonomic questionnaire with a scale from 1- 5, 1 being strongly disagree to 5 being strongly agree on a five-point Likert scale.
immediately after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

April 4, 2025

First Submitted That Met QC Criteria

April 4, 2025

First Posted (Actual)

April 11, 2025

Study Record Updates

Last Update Posted (Actual)

December 18, 2025

Last Update Submitted That Met QC Criteria

December 11, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 80334

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Subscribe